A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
Zurück zur Übersicht
19
How would I approach this? Possible Framework?
2
4,5k
Schreibe die erste Antwort!
Bisher hat niemand auf diese Frage reagiert.
Beste Antwort
Vlad
bearbeitet am 5. Juni 2018
Coach
McKinsey / Accenture Alum / Got all BIG3 offers / Harvard Business School
Hi,
Hi,
I recommend starting with clarifying the objective - Which metrics you need to achieve with the product? Most probably it will be ROI.
I would also clarify whether it's our painkiller on the market or the product of the competitors since competition and cannibalization are the two different cases. Then I will follow up with the structure:
Analyze our product:
- The value proposition of a product compared to the painkiller
- Different use cases of a product compared to the painkiller
- Unit economics (Current unit costs and costs in relation to scale, Investments, ROI targets, Competitor / substitutes pricing)
- Key capabilities to compete (Patent, distribution, etc)
Analyze the market:
- Size and growth rates of the painkiller market
- Size and growth rate of headache drugs
- Regulation - are they both OTC? Prescribed? Is it different by geography?
Analyze the competitors:
- Market shares, growth rates, profits
- Product (Value proposition)
- Unit economics (Value proposition vs. price vs. costs)
- Key capabilities (Distribution, supply, assets, knowledge, etc)
investment decision:
- Costs, benefits, and investments
- ROI
- Risks
Best!
0 Kommentare
Sidi
am 5. Juni 2018
Coach
McKinsey Senior EM & BCG Consultant | Interviewer at McK & BCG for 7 years | Coached 500+ candidates secure MBB offers
Hi Anonymous,
the new drug should be launched if the net value associated with this move exceeds the investment cost over the client's target investment horizon. Morover, Risk needs to be manageable.
So you have 4 buckets to investigate:
- Net value (expected profits of new drug + impact on profits of current painkiller (potential cannibalization!))
- Investment Horizon
- Investment need for launch of the new drug
- Wider risks associated with the new drug (regulation? competitive responses? consumer sentiment?...)
Cheers, Sidi
Jetzt kostenlos anmelden, um alle Antworten zu lesen.
Jetzt kostenlos anmelden, um alle Antworten zu lesen.
Ähnliche Fragen
Beliebteste Beiträge
My biggest fear
9
am 15. Apr. 2026
Europa
10
100+
Beste Antwort von
Franco
Coach
Ex BCG Principal & Global Interviewer (10+ Years) | 100+ MBB Offers | 95% Success Rate
10 Antworten
100+ Aufrufe
+7
How do referral work?
8
am 15. Apr. 2026
Europa
9
200+
Beste Antwort von
Franco
Coach
Ex BCG Principal & Global Interviewer (10+ Years) | 100+ MBB Offers | 95% Success Rate
9 Antworten
200+ Aufrufe
+6
I got fired from a T2 and struggling to find a job
10
am 16. Apr. 2026
UK
8
100+
Beste Antwort von
Franco
Coach
Ex BCG Principal & Global Interviewer (10+ Years) | 100+ MBB Offers | 95% Success Rate
8 Antworten
100+ Aufrufe
+5
Not getting responses from LinkedIn outreach or post-event follow-ups — what am I doing wrong?
15
am 17. Apr. 2026
USA
8
100+
Beste Antwort von
Soheil
Coach
INSEAD | EM & Strategy Consultant | 3.5Y Consulting | 5★ Case Coach | 350+ Cases | 50+ Live Interviews | MBB-Level
8 Antworten
100+ Aufrufe
+5
Question: "Is there something we haven't asked you that we should?"
9
am 20. Apr. 2026
Europa
10
200+
Beste Antwort von
Soheil
Coach
INSEAD | EM & Strategy Consultant | 3.5Y Consulting | 5★ Case Coach | 350+ Cases | 50+ Live Interviews | MBB-Level
10 Antworten
200+ Aufrufe
+7